Internet Explorer does not cooperate with this site. Please see below for options that work with APNA eLearning.*

5022-20:  Suicide in Women Veterans: The Too Silent Killer

Women Veterans are at high risk of death by suicide. Interprofessional, trauma-informed care includes screening for suicide, IPV, MST, and ACEs. Evidence supports this trauma-informed approach will decrease death by suicide in Women Veterans.  

Presenters:  Rachel M. Shaw, MSN, CRNP, PMHNP-BC; Mariah D. McCrear, MSN, CRNP, PMHNP-BC; Scarlet N. Patterson, MSN, CRNP, PMHNP-BC; Brenda L. Mayfield, MSN, CRNP, PMHNP-BC; Jessica W. Richardson, DNP, CRNP, PMHNP-BC; Teena M. McGuinness, PhD, PMHNP-BC, FAANP, FAAN

Disclosures:  The APNA planners and faculty have no relevant financial relationships to disclose.  Off-label uses will not be discussed during this presentation.

Session Length: 45 minutes

Target Audience:  RN, APRN

Learning Outcome:
Upon completion of this presentation, the participant will be able to:

• Summarize the higher risks associated with suicide among Women Veterans which include IPV, MST, and ACEs.

Keywords: Women Veterans, Suicide, Trauma-Informed Care 

Nursing Continuing Professional Development:
0.75 contact hours.  * In order to receive contact hours, you must: Listen to presentation, complete an evaluation, and earn a passing score on the post-test before the expiration date. You will have 5 tries to correctly answer the questions on the post-test and a score of 80% is required to pass. Once you have passed and completed an evaluation, the certificate will be generated online, available for you to print immediately. You cannot earn credit unless all steps are completed.

The American Psychiatric Nurses Association is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.

Originally Presented
APNA 34th Annual Conference

Access to this course will end:  December 1, 2024

*For an uninterrupted learning experience, please download and use Google Chrome, Mozilla Firefox, Microsoft Edge, Safari, etc. If you continue to experience issues, you may need to update your browser.